-
Predicting iPFS and EGFR-TKI Efficacy in EGFR-Mutated Lung Adenocarcinoma with Brain Metastases
23 Apr 2024 20:50 GMT
… EGFR-mutated lung adenocarcinoma with brain metastases,” published in the March … EGFR-mutated lung adenocarcinoma and brain metastases undergoing third-generation EGFR … lung adenocarcinoma patients with brain metastases receiving third-generation EGFR- …
-
The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions
23 Apr 2024 12:42 GMT
… histology type, and history of brain metastasis.
The primary endpoint was PFS … Asian). Patients with untreated brain metastases were additionally excluded from PAPILLON … patients with brain metastases. The incidence of developing brain metastases in patients …
-
AST-001 by Ascentawits Pharmaceuticals for Rectal Cancer: Likelihood of Approval
23 Apr 2024 03:29 GMT
… lung cancer with brain metastasis and acute lymphoblastic leukemia with brain metastasis.
For a …
-
NovoCure : Corporate responsibility report
22 Apr 2024 17:37 GMT
… the treatment of ovarian cancer, brain metastases from non-small cell lung … cancer (NSCLC) (brain metastases) and pancreatic cancer. Its key … investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer …
-
Medical Marvels
22 Apr 2024 15:06 GMT
… reach surgically or through medication. Brain metastases are a common result of … FUS as a treatment for brain metastases related to breast cancer. Researchers …
-
Alectinib Significantly Improves Disease-Free Survival in ALK-Positive NSCLC
20 Apr 2024 22:35 GMT
… that the few cases of brain metastases they saw—3.1% of …
-
Roche Alecensa gets USFDA nod for ALK-positive early-stage lung cancer
20 Apr 2024 09:27 GMT
… a higher risk of developing brain metastases than those with other types …
-
Synchronous Double Primary Tumors of Liver (Small Cell Neuroendocrine Carcinoma and Hepatocellular carcinoma): A Case Report
20 Apr 2024 07:43 GMT
… the presence of a new brain metastasis in the left parietal lobes …
-
Roche's Alecensa gets US FDA approval for adjuvant treatment for people with ALK─positive early─stage lung cancer
20 Apr 2024 05:50 GMT
… a higher risk of developing brain metastases than those with other types …
-
FDA Approves Alectinib to Treat Patients With ALK-Positive NSCLC
19 Apr 2024 21:32 GMT
… a higher risk of developing brain metastases than those with other types …